Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 2 of 2 results for finerenone

  1. Finerenone for treating chronic kidney disease in type 2 diabetes (TA877)

    Evidence-based recommendations on finerenone (Kerendia) for stage 3 and 4 chronic kidney disease (with albuminuria) associated with type 2 diabetes in adults.

    Technology appraisal guidance
    Published
    23 March 2023
    View recommendations

    Sections for TA877

  2. Finerenone for treating heart failure with preserved or mildly reduced ejection fraction ID6514

    Awaiting development [GID-TA11651] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development